Accessing this content is a benefit of AAGL Membership
To continue, please log into your AAGL membership account:

AAGL Username

Password

LOGIN
CANCEL

Click on the poster above to navigate to the next slide
 



  • OUR MISSION

    ”Focused on the ultimate goal of improving patient care in gynecologic medicine, AAGL recognizes that surgical gynecologists and other clinicians require lifelong learning. Accordingly, the AAGL provides a variety of educational activities to ensure the learners achieve this goal.“

  • WHAT'S NEW AT AAGL
    • Advincula-316x398

      From the Desk of the AAGL President


      Dear Colleagues,

      As many of you know, in the preceding months there have been communications from the FDA and numerous societal discussions as it relates to two very important surgical devices in our gynecologic armamentarium: the Essure for hysteroscopic sterilization and the mesh midurethral slings for stress urinary incontinence. This recent focus on two of our minimally invasive surgical treatments is consistent with the fact that the surgical healthcare landscape in gynecology has continued to come under fire over the last several years. Patient concerns, medico-legal targeting, and public misinformation have driven much of the scrutiny.

      As a result, I would like to bring to your attention two very important documents. The first is our AAGL Advisory Statement on the Essure device. It was developed with the intent to provide an unbiased, evidence-based view of the critical aspects of hysteroscopic sterilization. The second is a joint position statement developed by AUGS and SUFU in order to justify the use of the mesh midurethral sling in the surgical management of stress urinary incontinence. This position statement, which outlines very nicely the safety and effectiveness of mesh midurethral slings, has been endorsed by the AAGL.

      I hope that you refer to these two documents to stay informed about developments in minimally invasive gynecologic surgery. Through the sharing of information and collaborative support of other societies with similar goals of elevating gynecologic surgery, the proper narratives in healthcare can be written.

      Advisory Statement on Essure Hysteroscopic Sterilization

      AUGS Position Statement on Mesh Midurethral Slingsfor Stress Urinary Incontinence

      Best,
      Arnold P. Advincula, MD



    • aagl-logo

      Abstracts 2016: Quantity AND Quality


      Our members continue to amaze us! This year’s Call for Abstracts is officially closed and we are excited to report that we received an impressive 870 abstracts – just 30 shy of last year’s record. Written abstracts continue to comprise almost 2X the number of video abstracts; however, we received 35 more videos this year. The category with the highest entries (35%) is Laparoscopic Surgeries, followed by Endometriosis (11.3%), and Hysteroscopy (10.7%) rounding out the top 3. Among the written abstracts, there is an increase in the Pelvic Pain and Oncology categories, while videos saw the greatest increase in Laparoscopic Surgeries, Robotics and Urogynecology/Vaginal Surg. All subspecialties are represented so we anticipate this year’s Congress will offer  interesting findings, fresh learnings, and global perspectives. Grading the abstracts is the next step in the process which began on May 9th. Thank you and good luck to all who submitted!



    AAGL – Advancing Minimally Invasive Gynecology Worldwide
    6757 Katella Avenue | Cypress, CA 90630
    (800) 554-2245 | (714) 503-6200
    AAGL would like to thank Lina for its generous support of many of our member services.